Invasive pulmonale Aspergillose
暂无分享,去创建一个
[1] H. Einsele,et al. Invasive Fungal Infection. , 2019, Deutsches Arzteblatt international.
[2] G. Behre,et al. Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO) , 2018, Mycoses.
[3] C. Beigelman-Aubry,et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[4] Felix Bongomin,et al. Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision , 2017, Journal of fungi.
[5] F. Maurer,et al. Neue mikrobiologische Diagnostikverfahren , 2017, Medizinische Klinik - Intensivmedizin und Notfallmedizin.
[6] J. Timsit,et al. Intensive care medicine research agenda on invasive fungal infection in critically ill patients , 2017, Intensive Care Medicine.
[7] D. Denning,et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] M. Christner,et al. Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study , 2016, Critical Care.
[9] J. Baddley,et al. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial , 2016, The Lancet.
[10] Johannes B Reitsma,et al. Galactomannan detection for invasive aspergillosis in immunocompromised patients. , 2015, The Cochrane database of systematic reviews.
[11] J. Rello,et al. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes , 2015, Critical Care.
[12] M. Antonelli,et al. How to manage aspergillosis in non-neutropenic intensive care unit patients , 2014, Critical Care.
[13] D. Denning,et al. Burden of serious fungal infections in Germany , 2014 .
[14] J. Rello,et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. , 2012, American journal of respiratory and critical care medicine.
[15] Patricia Muñoz,et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] D. Denning,et al. Laboratory diagnosis of invasive aspergillosis. , 2005, The Lancet. Infectious diseases.
[17] J. Garnacho-Montero,et al. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome , 2005, Critical care.
[18] A. Wilmer,et al. Invasive aspergillosis in critically ill patients without malignancy. , 2004, American journal of respiratory and critical care medicine.
[19] H. Kauczor,et al. Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.